Results 211 to 220 of about 425,664 (357)

Shiitake Dermatitis

open access: yesNew England Journal of Medicine, 2023
Janusonyte, Egle, Puenchera, Jöri
openaire   +2 more sources

Successful Lebrikizumab Therapy in Two Patients With Atopic Dermatitis Resistant to Multiple Therapies

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT The treatment landscape for moderate‐to‐severe atopic dermatitis (AD) has evolved significantly with the introduction of novel targeted therapies addressing specific pathogenic mechanisms of the disease. Despite this therapeutic revolution, a proportion of patients experience intolerance and/or inadequate response to multiple lines of ...
Elena Ippoliti   +5 more
wiley   +1 more source

Predictive value of 8-hydroxy-2'-deoxyguanosine and 8-nitroguanine production in radiation-induced skin damage after postoperative breast cancer radiotherapy. [PDF]

open access: yesExplor Target Antitumor Ther
Verigos EK   +9 more
europepmc   +1 more source

Pilot Study of Tildrakizumab in the Treatment of Stable Non‐Segmental Vitiligo

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Treatment for vitiligo is limited, with variable efficacy, and can be time‐consuming or expensive. Recent developments within biologic therapy have demonstrated promising results with managing chronic autoimmune conditions. Objectives To evaluate the efficacy of tildrakizumab in inducing repigmentation in vitiligo.
Henry Lee   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy